By the end of March, the regulator could clear a highly anticipated pain drug from Vertex and a heart drug that’s critical to Alnylam’s future.

Coloradans will soon be able to take psychedelic mushrooms in a regulated environment as the state’s natural medicine program ...

Among the FDA’s pending decisions for this quarter are Vertex’s non-opioid pain drug and Sanofi’s RNA interference therapy ...

Scott Gottlieb and Luciana Borio, a former director for medical and biodefense preparedness policy at the National Security ...

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapie ...

Four men approached a group of 15 young people in line outside Amazura Concert Hall and fired about 30 rounds, New York Police Department Chief of Patrol Philip Rivera said at a news conference early ...

With two earlier trials meeting their primary endpoints, Axsome claimed it has the data to support a filing for FDA approval ...

Demand for Texas-grown Christmas trees continues to rise as acreage and entrepreneurial interest in farms expands, according ...

Check out all our end-of-year content—the latest Heart Sounds podcast reviews the reporters’ own favorite stories for 2024, ...

The battle against rectal cancer has entered an extraordinary new phase with the advent of immunotherapy, offering hope to ...

Western Carolina hosts the Furman Paladins after Bernard Pelote scored 24 points in Western Carolina's 78-69 victory over the Milligan Buffs.

Bristol-Myers Squibb has rebounded strongly in 2024, driven by key drug approvals and positive financial performance. See why ...